CIK 0001846253
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
OmniAb, Inc.
Sign in to watch- Ticker
- OABI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-250-7800
- Business address
- 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
- Former names
- Avista Public Acquisition Corp. II
Securities
- OABI Common Stock Nasdaq
- OABIW Warrant Nasdaq
- 4 Exercise or conversion Director acquired 13,172 shares (option exercise)
- 4 Open-market sale Chief Legal Officer sold 8,044 shares at $1.96 ($15,766)
- 4 Open-market sale Executive VP, Finance and CFO sold 23,922 shares at $1.96 ($46,887)
- 4 Open-market sale President and CEO sold 13,666 shares at $1.96 ($26,785)
- 4 Open-market buy Director bought 77,261 shares at an average $1.39 ($107,707)
- 4 Exercise or conversion Director acquired 17,769 shares (option exercise)
- 4 Exercise or conversion Director acquired 13,333 shares (option exercise)
- 4 Grant or award President and CEO acquired 540,540 shares (grant or award)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Open-market buy Director bought 30,000 shares at $1.52 ($45,600)
- 4 Open-market buy Director bought 25,000 shares at $1.46 ($36,500)
- 4 Open-market buy Director bought 65,000 shares at $1.44 ($93,600)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 2 of 9 · 174 filings